Cargando…
Comparative safety and effectiveness of long-acting inhaled agents for treating chronic obstructive pulmonary disease: a systematic review and network meta-analysis
OBJECTIVE: To compare the safety and effectiveness of long-acting β-antagonists (LABA), long-acting antimuscarinic agents (LAMA) and inhaled corticosteroids (ICS) for managing chronic obstructive pulmonary disease (COPD). SETTING: Systematic review and network meta-analysis (NMA). PARTICIPANTS: 208...
Autores principales: | Tricco, Andrea C, Strifler, Lisa, Veroniki, Areti-Angeliki, Yazdi, Fatemeh, Khan, Paul A, Scott, Alistair, Ng, Carmen, Antony, Jesmin, Mrklas, Kelly, D'Souza, Jennifer, Cardoso, Roberta, Straus, Sharon E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636655/ https://www.ncbi.nlm.nih.gov/pubmed/26503392 http://dx.doi.org/10.1136/bmjopen-2015-009183 |
Ejemplares similares
-
Safety and effectiveness of long-acting versus intermediate-acting insulin for patients with type 1 diabetes: protocol for a systematic review and individual patient data network meta-analysis
por: Veroniki, Areti Angeliki, et al.
Publicado: (2015) -
Comparative-effectiveness research of COVID-19 treatment: a rapid scoping review
por: Pham, Ba, et al.
Publicado: (2022) -
Impact of changes to reimbursement of fixed combinations of inhaled corticosteroids and long-acting β(2)-agonists in obstructive lung diseases: a population-based, observational study
por: Björnsdóttir, U S, et al.
Publicado: (2014) -
Comparative safety and effectiveness of serotonin receptor antagonists in patients undergoing chemotherapy: a systematic review and network meta-analysis
por: Tricco, Andrea C., et al.
Publicado: (2016) -
Using a distribution-based approach and systematic review methods to derive minimum clinically important differences
por: Watt, Jennifer A., et al.
Publicado: (2021)